Pharmacovigilance

7 posts
View Post
  • 5 min

Recent Drug Safety Alerts – Asrar Qureshi’s Blog Post #1125

Asrar Qureshi’s Blog Post 1125 discusses post-marketing surveillance and pharmacovigilance efforts in reporting adverse drug reactions. It highlights recent FDA warnings about cetirizine, scopolamine patches, and mRNA COVID-19 vaccines concerning severe side effects, urging that this information be treated as essential for discussions among healthcare professionals.
Share
View Post
  • 5 min

Why Pakistan’s Pharmaceutical Exports Lag Behind and How to Fix It– Asrar Qureshi’s Blog Post #1124

Pakistan’s pharmaceutical exports are notably low despite having a robust industry, with challenges including inadequate investment in facilities, lack of international certifications, inconsistent compliance with quality standards, and insufficient market intelligence. Strategic reforms, including regulatory improvements and investment in workforce development, are essential for enhancing exports and achieving global competitiveness.
Share
View Post
  • 5 min

AI and Machine Learning in Pharmaceutical Drug Development – Asrar Qureshi’s Blog Post #1102

The blog post by Asrar Qureshi discusses the transformative impact of Artificial Intelligence (AI) and Machine Learning (ML) on the pharmaceutical industry. It highlights innovations in drug discovery, preclinical development, clinical trials, and manufacturing, emphasizing efficiency and personalized medicine. However, challenges like data privacy and regulatory uncertainty must be addressed.
Share